Residents of Texas might remember hearing about Roundup, which used to be a popular line of weed-killing products. Unfortunately, this product contained ingredients that could cause cancer, but the company behind Roundup did not disclose the cancer-related risks of using its products.
Details about Monsanto’s announced settlement
In recent years, Roundup has become the target of mutlidistrict litigation. This lawsuit accuses Monsanto and Bayer AG, the companies behind Roundup, of selling their products illegally by not acknowledging the risks of using these weed killers. To try to resolve this lawsuit, Monsanto announced that it will pay up to $45 million in settlement costs.
If it gets approved, this settlement would allow consumers to receive up to 20% of the retail price of any previously purchased Roundup products. However, this settlement fund would not resolve lawsuits pertaining to cancer-related injuries. In a statement from Monsanto, it said the company believes that the $45 million settlement is “financially reasonable.”
Other lawsuits aimed at Roundup
It’s important to note that the above lawsuit isn’t the only one facing Monsanto and its parent company, Bayer AG. Monsanto and Bayer AG are also facing more than 100,000 lawsuits from people with cancer who were exposed to Roundup products. These lawsuits became stalled after a federal judge called Bayer’s offer to settle for $2 billion “clearly unreasonable.”
This case highlights the financial obligations that companies may have to individuals who are defrauded or otherwise injured by defective products. Individuals who have been harmed by a product may want to talk to an attorney about holding the manufacturer liable with a lawsuit or joining already existing litigation.